A cylindrical glass vial (b) probably stopped with a rubber stopper and sealed with a metal cap moulded around the neck and lip; vial is in a cardboard box (a)
A cylindrical glass vial (b) probably stopped with a rubber stopper and sealed with a metal cap moulded around the neck and lip; vial is in a cardboard box (a)
Number Of Parts
2
Part Names
a - box - Size: Length 8.5 cm x Width 3.6 cm x Depth 3.6 cm
(a) Front: "30 C.C. (1 oz.) // STERI-VIAL // BISMUTH SALICYLATE // IN OIL // WITH CHLORETONE // (BISMUTH SUBSALICYLATE) // For intramuscular // Injection // EACH C.C. CONTAINS: // Bismuth Sal- // icylate 0.13 Gm // (2 grs.) // Chloretone // (Chlorbutol) 3% // Phemerol Octyl- // oxyacetate* 1:2000 // Peanut Oil – q.s. // SEE SIDE PANELS // PARKE, DAVIS & CO. // WALKERVILLE, ONTARIO"; right side: "This suspension should be shaken before use. // ADULT DOSE – 1 to 1 1/2 c.c. intramuscularly, once weekly. // (0.13 to 0.2 Gm. of Bismuth Salicylate) // DO NOT GIVE INTRAVENOUSLY // "Steri-vial" designates certain sterile multiple // dose packages supplied by Parke, Davis & Co."; back: "PARKE, DAVIS & CO. // Laboratories // [9 cities listed] // Branches // [22 cities listed]"; left side: "This suspension contains finely powdered Bismuth // Salicylate in peanut oil, with Chloretone (Chlor- // butol) as a local anesthetic and Phemerol Octyl- // oxyacetate as a germicidal agent. // Each cc. contains 0.13 Gm (2 grs.) of Bismuth // Salicylate, equivalent to 75 mg. metallic bismuth. // *Para-tertiary-octyl-phenoxy-ethoxy-ethyl-dimethyl-benzyl // ammonium octyloxyacetate, P. D. & Co."; top: logo, see drawing on accession sheet; bottom: "JW [handwritten]"; (b) front: "30 C.C. // STERI-VIAL // BISMUTH SALICYLATE // IN OIL // WITH CHLORETONE // (Bismuth Subsalicylate) // EACH C.C. CONTAINS: [printed] C773709 [stamped] // Bismuth Salicylate – 0.13 Gm. (2 gr.) // Chloretone (Chlorbutol) – – 3% // Phemerol Oxyloxyacetate* – 1:2000 // Peanut Oil – – – – q.s. // For Intramuscular Injection. // [above 6 lines are written over a logo - see drawing on accession sheet] PARKE, DAVIS & CO., LTD. // WALKERVILLE, ONTARIO"; back: " "Steri-vial" designates certain sterile // multiple dose packages supplied by Parkee, Davis & Company. // Suspension – Should // be shaken before use. // An oversize container is supplied // to facilitate shaking. // ADULT DOSE – 1 to 1 1/2 c.c. intra- // muscularly, once weekly. // (0.13 to 0.2 Gm. of Bismuth // Salicylate) // Do Not Give Intravenously. // *Para-tertiary-octyl-phenoxy-// ethoxy-ethyl-dimethyl-benzyl // ammonium octyloxyacetate, // P.D. & Co."; bottom: "TCW CO // 1 S 114 // USA [embossed]"; top: "TEAR // OFF [embossed]"
Permanent Location
Storage Room 0010
0010-A3-5 Row D
Condition Remarks
Box yellowing, somewhat dented; label on vial yellowing; there is a sticky accretion around seal on metal cap; appears that contents of vial have leaked out